Bordetella pertussis autotransporter Vag8 binds human C1 esterase inhibitor and confers serum resistance

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Marr, Nico ^a,b   Shah, Nita R ^a   Lee, Rose ^a   Kim, Emma J ^a,b   Fernandez, Rachel C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTRANSPORTER PROTEIN VAG8; BACTERIAL PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; HISTIDINE; HYBRID PROTEIN; UNCLASSIFIED DRUG; MUTANT PROTEIN;

ARTICLE; BIOINFORMATICS; BORDETELLA PERTUSSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN PURIFICATION; WILD TYPE; BACTERIAL GENE; BIOASSAY; GENE LOCUS; GENETICS; MASS SPECTROMETRY; METABOLISM; MICROBIOLOGY; MOLECULAR WEIGHT; MUTATION; SERUM;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

BACTERIAL PROTEINS; BIOLOGICAL ASSAY; BORDETELLA PERTUSSIS; COMPLEMENT C1 INHIBITOR PROTEIN; GENES, BACTERIAL; GENETIC LOCI; HUMANS; MASS SPECTROMETRY; MOLECULAR WEIGHT; MUTANT PROTEINS; MUTATION; PROTEIN BINDING; SERUM;

EID: 79958795335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020585     Document Type: Article

References (42)

1. Tomlinson S, (1993) Complement defense mechanisms. Curr Opin Immunol 5: 83-89.
2. Persson CG, Erjefalt I, Alkner U, Baumgarten C, Greiff L, et al. (1991) Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy 21: 17-24.
3. Greiff L, Andersson M, Erjefalt JS, Persson CG, Wollmer P, (2003) Airway microvascular extravasation and luminal entry of plasma. Clin Physiol Funct Imaging 23: 301-306.
4. Morgan BP, Harris CL, (1999) Complement regulatory proteins San Diego Academic Press.
5. Cummings CA, Bootsma HJ, Relman DA, Miller JF, (2006) Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol 188: 1775-1785.
6. Uhl AM, Miller JF, (1995) Bordetella pertussis BvgAS Virulence Control System. In: Hoch JAS, T. J., editors. Two-Component Signal Transduction Washington, DC American Society for Microbiology pp. 333-349.
7. Carbonetti NH, (2007) Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr Opin Pharmacol 7: 272-278.
8. Mills KH, (2001) Immunity to Bordetella pertussis. Microbes Infect 3: 655-677.
9. Preston A, Allen AG, Cadisch J, Thomas R, Stevens K, et al. (1999) Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun 67: 3763-3767.
10. Byrd DW, Roop RM, Veit HP, Schurig GG, (1991) Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis. J Med Microbiol 34: 159-165.
11. Fernandez RC, Weiss AA, (1994) Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect Immun 62: 4727-4738.
12. Barnes MG, Weiss AA, (2001) BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect Immun 69: 3067-3072.
13. Berggard K, Lindahl G, Dahlback B, Blom AM, (2001) Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. European Journal of Immunology 31: 2771-2780.
14. Berggard K, Johnsson E, Mooi FR, Lindahl G, (1997) Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infection & Immunity 65: 3638-3643.
15. Fernandez RC, Weiss AA, (1998) Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol Lett 163: 57-63.
16. Marr N, Luu RA, Fernandez RC, (2007) Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing. J Infect Dis 195: 585-588.
17. Marr N, (2007) [Ph.D. thesis]: University of Wuerzburg, Germany.
18. Leininger E, Roberts M, Kenimer JG, Charles IG, Fairweather N, et al. (1991) Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A 88: 345-349.
19. Finn TM, Shahin R, Mekalanos JJ, (1991) Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis. Infection & Immunity 59: 3273-3279.
20. Weiss AA, Johnson FD, Burns DL, (1993) Molecular characterization of an operon required for pertussis toxin secretion. Proc Natl Acad Sci U S A 90: 2970-2974.
21. Weiss AA, Melton AR, Walker KE, Andraos-Selim C, Meidl JJ, (1989) Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infection & Immunity 57: 2674-2682.
22. Stibitz S, Weiss AA, Falkow S, (1988) Genetic analysis of a region of the Bordetella pertussis chromosome encoding filamentous hemagglutinin and the pleiotropic regulatory locus vir. J Bacteriol 170: 2904-2913.
23. Weiss AA, Hewlett EL, Myers GA, Falkow S, (1983) Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 42: 33-41.
24. Gauthier A, Finlay BB, (2003) Translocated intimin receptor and its chaperone interact with ATPase of the type III secretion apparatus of enteropathogenic Escherichia coli. J Bacteriol 185: 6747-6755.
25. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D, (2004) Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 68: 692-744.
26. Oliver DC, Huang G, Nodel E, Pleasance S, Fernandez RC, (2003) A conserved region within the Bordetella pertussis autotransporter BrkA is necessary for folding of its passenger domain. Mol Microbiol 47: 1367-1383.
27. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, et al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nature Genetics 35: 32-40.
28. Finn TM, Amsbaugh DF, (1998) Vag8, a Bordetella pertussis bvg-regulated protein. Infection & Immunity 66: 3985-3989.
29. Barnes MG, Weiss AA, (2002) Growth phase influences complement resistance of Bordetella pertussis. Infect Immun 70: 403-406.
30. Serruto D, Rappuoli R, Scarselli M, Gros P, van Strijp JA, (2010) Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol 8: 393-399.
31. Lambris JD, Ricklin D, Geisbrecht BV, (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132-142.
32. Lathem WW, Bergsbaken T, Welch RA, (2004) Potentiation of C1 Esterase Inhibitor by StcE, a Metalloprotease Secreted by Escherichia coli O157:H7. J Exp Med 199: 1077-1087.
33. Pillai L, Sha J, Erova TE, Fadl AA, Khajanchi BK, et al. (2006) Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophila. Infect Immun 74: 3742-3755.
34. Sebaihia M, Preston A, Maskell DJ, Kuzmiak H, Connell TD, et al. (2006) Comparison of the Genome Sequence of the Poultry Pathogen Bordetella avium with Those of B. bronchiseptica, B. pertussis, and B. parapertussis Reveals Extensive Diversity in Surface Structures Associated with Host Interaction. J Bacteriol 188: 6002-6015.
35. Hewitt M, Canning BJ, (2010) Coughing precipitated by Bordetella pertussis infection. Lung 188 (Suppl 1): S73-79.
36. Kovach ME, Phillips RW, Elzer PH, Roop RM 2nd, Peterson KM, (1994) pBBR1MCS: a broad-host-range cloning vector. Biotechniques 16: 800-802.
37. Cotter PA, Miller JF, (1997) A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol 24: 671-685.
38. Fuchslocher B, Millar LL, Cotter PA, (2003) Comparison of bipA alleles within and across Bordetella species. Infect Immun 71: 3043-3052.
39. Weingart CL, Broitman-Maduro G, Dean G, Newman S, Peppler M, et al. (1999) Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun 67: 4264-4267.
40. Shannon JL, Fernandez RC, (1999) The C-terminal domain of the Bordetella pertussis autotransporter BrkA forms a pore in lipid bilayer membranes. J Bacteriol 181: 5838-5842.
41. Oliver DC, Fernandez RC, (2001) Antibodies to BrkA augment killing of Bordetella pertussis. Vaccine 20: 235-241.
42. Rappsilber J, Ishihama Y, Mann M, (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 75: 663-670.